Timolol - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:55:43Z

Switch SMW query from broadtable to table format for better layout with TOC

← Older revision		Revision as of 21:55, 20 March 2026
Line 57:		Line 57:
	\|?Has Route=Route		\|?Has Route=Route
	\|?Has Population=Population		\|?Has Population=Population
	\|format=~~broadtable~~		\|format=table
	\|headers=plain		\|headers=plain
	\|mainlabel=-		\|mainlabel=-

Danbot: Add SMW Indications by Condition query table

2026-03-20T18:33:46Z

Add SMW Indications by Condition query table

← Older revision		Revision as of 18:33, 20 March 2026
Line 47:		Line 47:

	==Comments==		==Comments==

			==Indications by Condition==
			''The following table is automatically generated from disease/condition pages across WikEM.''

			{{#ask:[[Has DrugName::Timolol]]
			\|?Has Indication=Indication
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|?Has Route=Route
			\|?Has Population=Population
			\|format=broadtable
			\|headers=plain
			\|mainlabel=-
			\|sort=Has Indication
			\|limit=50
			}}


	==See Also==		==See Also==

Elcatracho: /* Administration */

2021-03-07T01:22:10Z

Administration

← Older revision		Revision as of 01:22, 7 March 2021
Line 3:		Line 3:
	*Dosage Forms:		*Dosage Forms:
	*Routes of Administration: topical (ophthalmic), oral		*Routes of Administration: topical (ophthalmic), oral
	*Common Trade Names:		*Common Trade Names: Betimol, Istalol

	==Adult Dosing==		==Adult Dosing==

Elcatracho: /* See Also */

2021-03-07T01:20:51Z

ClaireLewis: /* References */

2019-09-23T23:01:38Z

References

← Older revision		Revision as of 23:01, 23 September 2019
Line 55:		Line 55:
	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			[[Category:Ophthalmology]]

ClaireLewis: Created page with "==Administration== Type: Beta blocker Dosage Forms: Routes of Administration: topical (ophthalmic), oral Common Trade Names: ==Adult Dosing== *0.25% to 0.5%: 1 drop..."

2016-11-07T21:46:30Z

Created page with "==Administration== *Type: Beta blocker *Dosage Forms: *Routes of Administration: topical (ophthalmic), oral *Common Trade Names: ==Adult Dosing== *0.25% to 0.5%: 1 drop..."

New page

==Administration==
*Type: [[Beta blocker]]
*Dosage Forms:
*Routes of Administration: topical (ophthalmic), oral
*Common Trade Names:

==Adult Dosing==
*0.25% to 0.5%: 1 drop in affected eye 1-2 times daily
*10-30mg PO BID (for systemic beta-blocker effects)

==Pediatric Dosing==
*0.25% to 0.5%: 1 drop in affected eye daily

==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C
*[[Lactation risk categories|Lactation risk]]: Infant risk is minimal
*Renal dosing:
*Hepatic dosing:

==Contraindications==
*Allergy to class/drug
*Oral drug contraindicated in:
**2nd or 3rd degree AV block, bradycardia
**Heart failure, cardiogenic shock
**Active asthma, severe COPD

==Adverse Reactions==
===Serious===
*Dysrhythmia, myocardial infarction
*Bronchospasm
===Common===
*Bradyarrythmia, hypotension, heart failure, angina
*Rash, pruritus
*Nausea/vomiting, diarrhea, abdominal pain
*Muscle cramps
*Dizziness, headache, confusion, fatigue
*Blurred vision, burning sensation in eye, dry eyes

==Pharmacology==
*Half-life: 4h (oral)
*Metabolism: hepatic, via CYP2D6
*Excretion: mostly renal

==Mechanism of Action==
*Nonselective beta-1 and beta-2 antagonist
*Decreases intraocular pressure by increasing outflow and decreasing formation of aqueous humor

==Comments==

==See Also==
*[[Beta blockers]]
*[[Acute angle-closure glaucoma]]

==References==
<references/>
[[Category:Pharmacology]]

← Older revision		Revision as of 01:20, 7 March 2021
Line 50:		Line 50:
	==See Also==		==See Also==
	*[[Beta blockers]]		*[[Beta blockers]]
			*[[Beta blocker toxicity]]
	*[[Acute angle-closure glaucoma]]		*[[Acute angle-closure glaucoma]]